Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
7 hedge funds and large institutions have $669K invested in Counterpath Corp in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
6% more capital invested
Capital invested by funds: $632K → $669K (+$37K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$440 |
CPAH Hedge Fund Activity: Q3 2016 in Review
7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q3 2016, worth a combined $669K — up 5.9% from $632K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CPAH positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $33.7K. The largest seller was Tower Research Capital (TRC), cutting an estimated $440.
- 7 institutional investors held Counterpath Corp (CPAH) as of Q3 2016, up from 6 in Q2 2016.
- Funds reported $669K of Counterpath Corp stock for Q3 2016, up 5.9% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q3 2016 and 0 closed out, a net change of +1 holder.
- The largest Counterpath Corp buyer in Q3 2016 was Royal Bank of Canada, an estimated $33.7K added.
- The largest Counterpath Corp seller in Q3 2016 was Tower Research Capital (TRC), an estimated $440 sold.
Based on aggregated 13F filings for Q3 2016.